Esya for Parkinson’s

The cellular pathophysiology of Parkinson's disease remains poorly understood.
Lysosomal homeostasis and protein degradation are affected in Parkinson's disease.


A 360-Degree Perspective for Parkinson's Disease based on Esya's patented DNA nanotechnology, unique biomarkers, and our multiomics platform

If you crave challenges, there's no better place to be

Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. ​If you crave challenges and the chance to see your work impact the millions of lives touched by Parkinson’s disease, there’s no better place to be.